← Go Back

Cell Death Database

Comprehensive RNA involved in Cell Death Pathways research database with advanced search and filtering capabilities

388 research entries found
RNA Name Mechanism of Action Effect on Cancer Reference
SIRT2
mRNA
NAD+-dependent deacetylase; modulates apoptosis via deacetylation of targets and ROS responses. Often amplified/overexpressed in TNBC and promotes survival; SIRT2 loss sensitizes cells to ROS-induced apoptosis. PMID: 27503926

External Database Search

Detailed Information

Apoptosis
mRNA
Breast Cancer

RNA Name: SIRT2

Mechanism of Action: NAD+-dependent deacetylase; modulates apoptosis via deacetylation of targets and ROS responses.

Effect on Cancer: Often amplified/overexpressed in TNBC and promotes survival; SIRT2 loss sensitizes cells to ROS-induced apoptosis.

PMID: 27503926
HRK
mRNA
BH3-only pro-apoptotic Bcl-2 family member; binds Bcl-2/Bcl-xL to release Bax/Bak and promote mitochondrial apoptosis. PMID: 30774992

External Database Search

Detailed Information

Apoptosis
mRNA
Breast Cancer

RNA Name: HRK

Mechanism of Action: BH3-only pro-apoptotic Bcl-2 family member; binds Bcl-2/Bcl-xL to release Bax/Bak and promote mitochondrial apoptosis.

Effect on Cancer:

PMID: 30774992
AIFM3
mRNA
Mitochondrial oxidoreductase similar to AIF; upon release can mediate caspase-independent apoptosis via chromatin condensation and DNA fragmentation. Overexpression in breast cancer linked to metastasis and poor prognosis. PMID: 31088422

External Database Search

Detailed Information

Apoptosis
mRNA
Breast Cancer

RNA Name: AIFM3

Mechanism of Action: Mitochondrial oxidoreductase similar to AIF; upon release can mediate caspase-independent apoptosis via chromatin condensation and DNA fragmentation.

Effect on Cancer: Overexpression in breast cancer linked to metastasis and poor prognosis.

PMID: 31088422
AKT1
mRNA
AKT1 (PKB?) is a serine/threonine kinase that promotes cell survival by phosphorylating/inactivating pro-apoptotic factors (BAD, FOXO), inhibiting caspase activation and promoting MDM2-mediated p53 degradation; isoform-specific effects exist in breast cancer. AKT1 activation impairs apoptosis and promotes tumor initiation in breast cancer; isoform-specific roles affect therapy response in TNBC. PMID: 31752925

External Database Search

Detailed Information

Apoptosis
mRNA
Breast Cancer

RNA Name: AKT1

Mechanism of Action: AKT1 (PKB?) is a serine/threonine kinase that promotes cell survival by phosphorylating/inactivating pro-apoptotic factors (BAD, FOXO), inhibiting caspase activation and promoting MDM2-mediated p53 degradation; isoform-specific effects exist in breast cancer.

Effect on Cancer: AKT1 activation impairs apoptosis and promotes tumor initiation in breast cancer; isoform-specific roles affect therapy response in TNBC.

PMID: 31752925
CASP3
mRNA
Executioner caspase that cleaves multiple substrates to execute apoptosis following activation by initiator caspases. Cleaved (active) caspase-3 in TNBC correlates with chemotherapy response and can be a marker of apoptosis. PMID: 31949833

External Database Search

Detailed Information

Apoptosis
mRNA
Breast Cancer

RNA Name: CASP3

Mechanism of Action: Executioner caspase that cleaves multiple substrates to execute apoptosis following activation by initiator caspases.

Effect on Cancer: Cleaved (active) caspase-3 in TNBC correlates with chemotherapy response and can be a marker of apoptosis.

PMID: 31949833
TP53
mRNA
TP53 encodes p53, a transcription factor that activates pro-apoptotic genes (BAX, PUMA/BBC3, NOXA) in response to DNA damage and stress, inducing mitochondrial apoptosis and cell-cycle arrest. TP53 is frequently mutated in breast cancer, especially TNBC; mutant p53 alters apoptosis and is associated with therapy response and prognosis. PMID: 32061310

External Database Search

Detailed Information

Apoptosis
mRNA
Breast Cancer

RNA Name: TP53

Mechanism of Action: TP53 encodes p53, a transcription factor that activates pro-apoptotic genes (BAX, PUMA/BBC3, NOXA) in response to DNA damage and stress, inducing mitochondrial apoptosis and cell-cycle arrest.

Effect on Cancer: TP53 is frequently mutated in breast cancer, especially TNBC; mutant p53 alters apoptosis and is associated with therapy response and prognosis.

PMID: 32061310
DLC1
mRNA
Tumor-suppressor RhoGAP activity; restoration of DLC1 expression reduces pro-survival signaling and promotes apoptosis. Curcumin restored DLC1 expression and promoted apoptosis in TNBC cell lines and xenografts. PMID: 32725802

External Database Search

Detailed Information

Apoptosis
mRNA
Breast Cancer

RNA Name: DLC1

Mechanism of Action: Tumor-suppressor RhoGAP activity; restoration of DLC1 expression reduces pro-survival signaling and promotes apoptosis.

Effect on Cancer: Curcumin restored DLC1 expression and promoted apoptosis in TNBC cell lines and xenografts.

PMID: 32725802
BIRC2
mRNA
Encodes cIAP1 which ubiquitinates caspases and inhibits apoptosis. Overexpressed in TNBC and promotes chemoresistance. PMID: 33673050

External Database Search

Detailed Information

Apoptosis
mRNA
Breast Cancer

RNA Name: BIRC2

Mechanism of Action: Encodes cIAP1 which ubiquitinates caspases and inhibits apoptosis.

Effect on Cancer: Overexpressed in TNBC and promotes chemoresistance.

PMID: 33673050
BIRC3
mRNA
Encodes cIAP2; inhibits caspases and activates NF-?B pro-survival signaling. Overexpressed in TNBC contributing to apoptosis resistance. PMID: 33673050

External Database Search

Detailed Information

Apoptosis
mRNA
Breast Cancer

RNA Name: BIRC3

Mechanism of Action: Encodes cIAP2; inhibits caspases and activates NF-?B pro-survival signaling.

Effect on Cancer: Overexpressed in TNBC contributing to apoptosis resistance.

PMID: 33673050
TRPC5
mRNA
Calcium channel; increased Ca2+ influx activates survival pathways and drug-resistance mechanisms. promotes drug resistance in breast carcinoma via CaMKK?/AMPK?/mTOR pathway PMID: 33426511

External Database Search

Detailed Information

Apoptosis
mRNA
Breast Cancer

RNA Name: TRPC5

Mechanism of Action: Calcium channel; increased Ca2+ influx activates survival pathways and drug-resistance mechanisms.

Effect on Cancer: promotes drug resistance in breast carcinoma via CaMKK?/AMPK?/mTOR pathway

PMID: 33426511